Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections
1 other identifier
observational
23
1 country
1
Brief Summary
The main focus of this observational study is to analyze the possible effects of cranberry dietary supplements on the intestinal microbiota in women with recurrent uncomplicated urinary tract infections. In a secondary analysis the possible influence of the microbiota changes on the recurrence frequency in the follow-up should be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 2, 2017
CompletedFirst Posted
Study publicly available on registry
January 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedFebruary 16, 2021
February 1, 2021
1.9 years
January 2, 2017
February 15, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Number of urinary tract infections
In the 6-month prospective observation period compared to a 6-month retrospective period
Secondary Outcomes (1)
Quality of life (SF-36)
Baseline, 4 weeks, 8 weeks, 6 months
Other Outcomes (1)
Stool analysis: Intestinal microbiome by sequencing 16S rRNA
Baseline, 4 weeks, 8 weeks, 6 months
Interventions
3 x Cystorenal Cranberry plus daily for 6 months (contains 300 mg Cranberry-Extract, 100 mg Pumpkin seeds-Extract, 20 mg Vitamin C und 0,47 mg Riboflavin)
Eligibility Criteria
Patients with chronic recurrent Urinary Tract Infections
You may qualify if:
- chronic recurrent urinary tract infections (≥3 infections per year or 2 infections in the last 6 months)
You may not qualify if:
- renal insufficiency (GFR \<60),
- anatomical or known structural causes of urinary tract infections
- regular consumption of probiotics or probiotic yogurts (at least 5x / week)
- intake of antibiotics in the last 4 weeks
- intake of Marcumar
- simultaneous participation in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus
Berlin, 14109, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Michalsen, Prof. Dr.
Charité University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. Andreas Michalsen
Study Record Dates
First Submitted
January 2, 2017
First Posted
January 13, 2017
Study Start
January 1, 2017
Primary Completion
December 1, 2018
Study Completion
February 1, 2019
Last Updated
February 16, 2021
Record last verified: 2021-02